Mr Mrs Miss Ms Dr Other

Dr
Laurence
Gainey

Partner & Patent Attorney

Manchester Office Alderley Park Office

Life sciences

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 778 545 8684
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Laurence is a highly-experienced European and UK qualified patent attorney with over 25 years’ experience handling pharmaceutical and biotechnology subject matter. He has successfully managed patent portfolios on a variety of biotechnology subject matter, including diagnostic tools and targets, personalised healthcare (PHC), antisense oligonucleotide molecules, peptide and antibody (e.g. polyclonal, monoclonal, bispecific and conjugated) therapeutics, as well as handling the IP for small molecule discovery and high profile on sale pharmaceutical products, some with greater than $1bn annual sales.

After gaining a PhD in molecular biology from Reading University, Laurence joined a small biotechnology company to work in the laboratory on virus-based antigen delivery systems. After a couple of years, he moved internally to train as a patent attorney. In the same year as qualifying as European patent attorney Laurence joined the in-house patent department of AstraZeneca Pharmaceutical Ltd. where he worked for over 18 years before joining HGF’s Manchester office as a Patent Director in September 2017.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Cell and Molecular Biology

PHD

Molecular Biology - Reading University

POSTGRADUATE DIPLOMA OR CERTIFICATE

Certificate in Intellectual Property Law - Queen Mary University of London

Publications

MBL Webinar entitled "Patent Due Diligence - The Fundamental Portfolio Checks Required"

View publication online

Chapter "Patent Considerations When Embarking on New Antisense Drug Programs" for the Open Access book "Antisense RNA Design, Delivery, and Analysis". "

View publication online

Related News

HGF ranked among Europe’s top patent firms in IP STARS Patent Rankings 2025

HGF has once again made a bold mark in the latest Managing IP Stars 2025 firm rankings, with top-tier recognition across multiple jurisdictions for our patent expertise. This year’s results …

Read article

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms …

Read article

HGF receives exceptional results in IAM Patent 1000 rankings 2025

We are proud to announce that HGF has once again achieved outstanding recognition in the IAM Patent 1000 – The World’s Leading Patent Professionals 2025. With 29 of our attorneys …

Read article

Innovation in the Energy Industry - Do You Have Freedom to Operate?

The energy transition has brought unprecedented change to the energy sector. Whilst change can bring uncertainty and challenges, it also brings opportunities. Many companies have already seized on the opportunity …

Read article

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

  This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as …

Read article
Event - 3rd June 2025

Salzburg Seminar: Patents, trademarks, intellectual property rights – how startups can act strategically

Young companies make many important decisions during the start-up phase. One of the most important questions is: How do I deal strategically with innovations, ideas, and brand development? Those who …

Event details

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us